Bahrain vs Lower-middle income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc)

Bahrain
99.0%
in 2025
Lower-middle income (World Bank)
81.0%
in 2025
Bahrain rank
1st
Lower-middle income (World Bank) rank
4th

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Bahrain
  • Lower-middle income (World Bank)
020406080100200820162025

How they compare

Bahrain currently reports 99.0% against 81.0% in Lower-middle income (World Bank), a difference of 18.0%.

That makes Bahrain's figure about 1.2 times Lower-middle income (World Bank)'s.

Across all 18 years both countries report, Bahrain has been ahead every year.

Bahrain ranks 1st and Lower-middle income (World Bank) ranks 4th of 194 countries.

Bahrain has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Bahrain Lower-middle income (World Bank) Difference Ahead
2000s 55.0% 0.0% 55.0% Bahrain
2010s 98.3% 24.9% 73.4% Bahrain
2020s 98.8% 68.0% 30.8% Bahrain

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Bahrain or Lower-middle income (World Bank)?
Bahrain, at 99.0% against 81.0% in Lower-middle income (World Bank) as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Bahrain and Lower-middle income (World Bank)?
18.0%, with Bahrain ahead.
How many years of comparable data are there for Bahrain and Lower-middle income (World Bank)?
18 years are reported by both, from 2008 to 2025.
How do Bahrain and Lower-middle income (World Bank) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Bahrain ranks 1st and Lower-middle income (World Bank) ranks 4th of 194 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Bahrain vs Lower-middle income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 31 August 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/bahrain/lower-middle-income-world-bank/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/bahrain/lower-middle-income-world-bank/">Bahrain vs Lower-middle income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed